Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

Circulation

Volumn 93, Issue 10, 1996, Pages 1860-1870

  Haynes, William G ^a   Ferro, Charles J ^a   O'Kane, Kevin P J ^a   Somerville, David ^a   Lomax, Charmaine C ^a   Webb, David J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

blood pressure; drugs; endothelin; hemodynamics; receptors; vasculature

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE; TAK 044; VASODILATOR AGENT;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0029886596     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.10.1860     Document Type: Article

References (46)

1. Yanagisawa M, Kurihawa H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci. 1993; 84:485-500.
3. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
4. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane bound metalloprotease that catalyses the proteolytic activation of big endothelin-1. Cell. 1994; 78:473-485.
5. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
6. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
7. B receptors in human vascular smooth muscle. J Cardiovasc Pharmacol. 1993;22(suppl 8): S22-S25.
8. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
9. B receptors mediate vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995;92:357-363.
10. Gardiner SM, Compton AM, Kemp PA, Bennett T. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats. Br J Pharmacol. 1991;103:2009-2015.
11. Douglas SA, Elliot JD, Ohlstein EH. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetised rat: effect of BQ-123 on systemic haemodynamic responses. Eur J Pharmacol. 1992;221:315-324.
12. A receptor. Life Sci. 1992;50:247-255.
13. B-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br J Pharmacol. 1994;112:823-830.
14. A receptor antagonist. J Cardiovasc Pharmacol. 1994;24:587-594.
15. Filep JG, Clozel M, Fournier A, Földes-Filep E. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Br J Pharmacol. 1994;113:845-852.
16. A) receptor antagonist in conscious rats. J Cardiovasc Pharmacol. 1992;20:940-948.
17. Nishikibe M, Tsuchida S, Okada M, Fukuroda T, Shimamoto K, Yano M, Ishikawa K, Ikemoto F. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ123, in a genetic hypertensive model. Life Sci. 1993;52:717-724.
18. McMahon EG, Palomo MA, Moore WM. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1991; 17(suppl 7):S29-S33.
19. A receptor activation. Am J Physiol. 1993;264:R222-R226.
20. Véniant M, Clozel JP, Hess P, Clozel M. Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs. Life Sci. 1994;55:445-454.
21. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
22. Hoffman A, Haramati A, Dalal I, Shuranyi E, Winaver J. Diuretic-natriuretic actions and pressor effects of big endothelin (1-39) in phosphoramidon treated rats. Proc Soc Exp Med Biol. 1994;205:168-173.
23. Warner TD, Allcock GH, Vane JR. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Br J Pharmacol. 1994; 112:207-213.
24. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-854.
25. Haynes WG, Noon J, Walker BR, Webb DJ. L-NMMA increases blood pressure in humans. Lancet. 1993;342:931-932.
26. B. Biochem Biophys Res Commun. 1994;200:1708-1712.
27. Kusumoto K, Kubo K, Kandori H, Kitayoshi T, Sato S, Wakimasu M, Watanabe T, Fujino M. Effects of a new endothelin antagonist TAK-044, on post-ischemic acute renal failure in rats. Life Sci. 1994;55:301-310.
28. B-mediated blood pressure responses in rats. J Pharmacol Exp Ther. 1994; 270:728-733.
29. B receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol. 1993; 114:949-954.
30. Löffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 1993;333: 108-110.
31. B receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
32. Appel PL, Kram HB, Mackabee J, Fleming AW, Shoemaker WC. Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Crit Care Med. 1986;14:933-935.
33. Salandin V, Zussa C, Risica G, Michielon P, Paccagnella A, Cipolotti G, Simini G. Comparison of cardiac output estimation by thoracic electrical bioimpedance, thermodilution, and Fick methods. Crit Care Med. 1988;16:1157-1158.
34. Northridge DB, Findlay IN, Wilson J, Henderson E, Dargie HJ. Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance. Br Heart J. 1990;63: 93-97.
35. Thomas SHL. Impedance cardiography using the Sramek-Bernstein method: accuracy and reproducibility at rest and during exercise. Br J Clin Pharmacol. 1992;34:467-476.
36. Haynes WG, Hand M, Johnstone H, Padfield PL, Webb DJ. Direct and sympathetically mediated venoconstriction in essential hypertension: enhanced responses to endothelin-1. J Clin Invest. 1994;94:1359-1364.
37. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (Lond). 1989;412:543-555.
38. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
39. Rosner B. Multisample inference: linear contrasts. In: Rosner B, ed. Fundamentals of Biostatistics. Boston, Mass: Duxbury Press; 1995:310-314.
40. Douglas SA, Gellai M, Ezekial M, Feuerstein GZ, Elliot JD, Ohlstein EH. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension. 1995;25:818-822.
41. Gray GA, Löffler BM, Clozel M. Characterization of endothelin receptors mediating contraction of rabbit saphenous vein. Am J Physiol. 1994;266:H959-H966.
42. Webb DJ, Manhem PJO, Ball SG, Inglis G, Leckie BJ, Lever AF, Morton JJ, Robertson JIS, Murray GD, Ménard J, Hallett A, Jones DM, Szelke M. A study of the renin inhibitor H142 in man. J Hypertens. 1985;3:653-658.
43. MacFayden RJ, Lees KR, Reid JL. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol. 1991;31:1-13.
44. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T, Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991;83:476-483.
45. Weiczorek I, Haynes WG, Ludlam C, Fox K, Webb DJ. Plasma endothelin predicts outcome in patients with unstable myocardial ischaemic syndromes. Br Heart J. 1994;72:436-441.
46. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Endothelin in myocardial infarction. Nature. 1990;344:114. Letter.